Methods comprising desmopressin
First Claim
Patent Images
1. A method for reducing nocturnal urine volume in a male patient in need thereof comprising:
- measuring the patient'"'"'s serum sodium level;
administering to the patient, with a serum sodium level of at least 135 mmol/L, prior to bedtime an orodispersible dose of desmopressin of 50 μ
g or 100 μ
g, wherein the dose is measured as the free base of desmopressin;
measuring the patient'"'"'s serum sodium level at a time interval after administration;
continuing the administration of the dose of desmopressin over a treatment period if the male patient has a serum sodium level of at least 130 mmol/L;
wherein the dose administered over the treatment period reduces the patient'"'"'s nocturnal urine volume.
2 Assignments
0 Petitions
Accused Products
Abstract
The present disclosure is directed to gender, age, and dose effects of desmopressin on reducing nocturnal voids, increasing an initial period of undisturbed sleep, and/or reducing nocturnal urine volume.
-
Citations
28 Claims
-
1. A method for reducing nocturnal urine volume in a male patient in need thereof comprising:
-
measuring the patient'"'"'s serum sodium level; administering to the patient, with a serum sodium level of at least 135 mmol/L, prior to bedtime an orodispersible dose of desmopressin of 50 μ
g or 100 μ
g, wherein the dose is measured as the free base of desmopressin;measuring the patient'"'"'s serum sodium level at a time interval after administration; continuing the administration of the dose of desmopressin over a treatment period if the male patient has a serum sodium level of at least 130 mmol/L; wherein the dose administered over the treatment period reduces the patient'"'"'s nocturnal urine volume. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 22, 23, 25)
-
-
13. A method for treating nocturia in a patient in need thereof based on the patient'"'"'s gender comprising:
-
determining the gender and the age of the patient; and administering to the patient an orodispersible dose of desmopressin prior to bedtime over a treatment period, the dose chosen from 10 μ
g or 25 μ
g of desmopressin for a female patient 65 years and younger, 25 μ
g for a female patient over 65 years, and 50 μ
g or 100 μ
g for a male patient with a serum sodium level of at least 135 mmol/L,wherein the dose is measured as the free base of desmopressin and wherein when the patient is male, measuring the male patient'"'"'s serum sodium level prior to administration, measuring the male patient'"'"'s serum sodium level at a time interval after administration, and continuing the administration of the dose of desmopressin to the male patient over a treatment period if the male patient has a serum sodium level of at least 130 mmol/L. - View Dependent Claims (14, 15, 16, 17, 18, 19, 20, 21, 24, 26)
-
-
27. A method for reducing nocturnal urine volume in a male patient in need thereof comprising:
-
measuring the patient'"'"'s serum sodium level; administering to the patient, with a serum sodium level of at least 135 mmol/L, approximately 1 hour prior to bedtime an orodispersible dose of desmopressin of 50 μ
g without water, wherein the dose is measured as the free base of desmopressin;measuring the patient'"'"'s serum sodium level at a time interval after administration; continuing the administration of the dose of desmopressin over a treatment period if the male patient has a serum sodium level of at least 130 mmol/L; wherein the dose administered over the treatment period reduces the patient'"'"'s nocturnal urine volume.
-
-
28. A method for treating nocturia in a patient in need thereof based on the patient'"'"'s gender comprising:
-
determining the gender and the age of the patient; and administering to the patient an orodispersible dose of desmopressin approximately 1 hour prior to bedtime without water, wherein the dose is chosen from 25 μ
g of desmopressin for a female patient and 50 μ
g for a male patient with a serum sodium level of at least 135 mmol/L,wherein the dose is measured as the free base of desmopressin and wherein when the patient is male, measuring the male patient'"'"'s serum sodium level prior to administration, measuring the male patient'"'"'s serum sodium level at a time interval after administration, and continuing the administration of the dose of desmopressin to the male patient over a treatment period if the male patient has a serum sodium level of at least 130 mmol/L.
-
Specification